Tuesday's Top 10 Articles, Videos on TheStreet
NEW YORK (TheStreet) -- In case you missed them, here are the top 10 most popular articles and videos on TheStreet today. Sign up for free email delivery of our daily Top 10.
22 Biopharma Stocks With Breakout Potential in 2012
Adam Feuerstein
TheStreet's Adam Feuerstein has compiled a list of drugs with crucial, stock-moving clinical trial catalysts for the remainder of 2012.
Ignore Headlines, Buy Health Care ETF
Gregg Greenberg
Ethan Anderson, senior portfolio manager at Rehmann Financial, says health care and technology ETFs should do well despite negative headlines.
5 Hated Stocks That You Should Love
Stockpickr Staff
Short-covering could trigger quick upward moves for these five stocks.
Marek Fuchs
This should have been a red flag for the Facebook IPO, and it echoes Amazon. Will Nokia, Microsoft Make Life Tough for Apple in China?
Rocco Pendola
AAPL bulls should pay attention to positive Windows Phone news out of China. BlackBerry Bold Shows RIM's Shrinking Niche
Jonathan Blum
Business features on the BlackBerry Bold remain excellent, but RIM devices are clearly losing ground to competitors. Stocks Rise After Housing Report
Andrea Tse
U.S. stocks trade higher Tuesday morning after a better-than-expected U.S. existing home sales report. Keep Hating on Facebook; Long-Term Investors Love Cheap Shares
Rocco Pendola
Standard IPO behavior and Facebook hate will help create one of 2012's best stock market bargains. Facebook and Nasdaq: Two Faces of Lost Credibility
Richard Saintvilus
Absent some 'influences,' Facebook likely would not have closed above $38 on its first day. Buy Dell Ahead of Earnings
Richard Saintvilus
A buy at eight times earnings, the one-time PC king is successfully repositioning for changing markets.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
